{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:32:03Z","timestamp":1787841123793,"version":"build-2784847793"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Biomed Eng"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10439-026-04028-6","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:31:28Z","timestamp":1772548288000},"page":"2991-3009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improving In Silico Cardiac Safety Prediction by Consensus Averaging of Transmural Ventricular Cell Models"],"prefix":"10.1007","volume":"54","author":[{"given":"Nurul Qashri","family":"Mahardika T","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Ikhsanul","family":"Qauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunendah Nur","family":"Fuadah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aulia Khamas","family":"Heikhmakhtiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Adnan","family":"Pramudito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ariyadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroli","family":"Marcellinus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Moo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"4028_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.vascn.2016.06.002","volume":"81","author":"T Colatsky","year":"2016","unstructured":"Colatsky, T., B. Fermini, G. Gintant, J. B. Pierson, P. Sager, Y. Sekino, D. G. Strauss, and N. Stockbridge. The comprehensive in vitro proarrhythmia assay (CiPA) initiative\u2014update on progress. J. Pharmacol. Toxicol. Methods. 81:15\u201320, 2016. https:\/\/doi.org\/10.1016\/j.vascn.2016.06.002.","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"4028_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/cpt.896","volume":"103","author":"J Vicente","year":"2018","unstructured":"Vicente, J., R. Zusterzeel, L. Johannesen, J. Mason, P. Sager, V. Patel, M. K. Matta, Z. Li, J. Liu, C. Garnett, N. Stockbridge, I. Zineh, and D. G. Strauss. Mechanistic model-informed proarrhythmic risk assessment of drugs: review of the \u201cCiPA\u201d initiative and design of a prospective clinical validation study. Clin. Pharmacol. Ther. 103:54\u201366, 2018. https:\/\/doi.org\/10.1002\/cpt.896.","journal-title":"Clin. Pharmacol. Ther."},{"key":"4028_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10928-018-9580-2","volume":"45","author":"S Polak","year":"2018","unstructured":"Polak, S., K. Romero, A. Berg, N. Patel, M. Jamei, D. Hermann, and D. Hanna. Quantitative approach for cardiac risk assessment and interpretation in tuberculosis drug development. J. Pharmacokinet. Pharmacodyn. 45:457\u2013467, 2018. https:\/\/doi.org\/10.1007\/s10928-018-9580-2.","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"4028_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2003.04.055","author":"RM Gowda","year":"2004","unstructured":"Gowda, R. M., I. A. Khan, S. L. Wilbur, B. C. Vasavada, and T. J. Sacchi. Torsade de pointes: The clinical considerations. 2004. https:\/\/doi.org\/10.1016\/j.ijcard.2003.04.055.","journal-title":"Torsade de pointes: The clinical considerations."},{"key":"4028_CR5","unstructured":"Shah, R. R. The significance of QT interval in drug development"},{"key":"4028_CR6","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.4.3.509","author":"I Cavero","year":"2005","unstructured":"Cavero, I., and W. Crumb. ICH S7B draft guideline on the non-clinical strategy for testing delayed cardiac repolarisation risk of drugs: a critical analysis. Expert Opin. drug saf. 2005. https:\/\/doi.org\/10.1517\/14740338.4.3.509.","journal-title":"Expert Opin. drug saf."},{"key":"4028_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/bcp.12477","volume":"79","author":"RR Shah","year":"2015","unstructured":"Shah, R. R., J. Morganroth, and R. B. Kleiman. ICH E14 Q&A(R2) document: commentary on the further updated recommendations on thorough QT studies. Br. J. Clin. Pharmacol. 79:456\u2013464, 2015. https:\/\/doi.org\/10.1111\/bcp.12477.","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"4028_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1087057115594589","volume":"21","author":"B Fermini","year":"2016","unstructured":"Fermini, B., J. C. Hancox, N. Abi-Gerges, M. Bridgland-Taylor, K. W. Chaudhary, T. Colatsky, K. Correll, W. Crumb, B. Damiano, G. Erdemli, and G. Gintant. A new perspective in the field of cardiac safety testing through the comprehensive in vitro proarrhythmia assay paradigm. J. Biomol. Screen. 21(1):1\u201311, 2016. https:\/\/doi.org\/10.1177\/1087057115594589.","journal-title":"J. Biomol. Screen."},{"key":"4028_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.11.004","author":"PT Sager","year":"2014","unstructured":"Sager, P. T., G. Gintant, J. R. Turner, S. Pettit, and N. Stockbridge. Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the cardiac safety research consortium. Am. heart J. 2014. https:\/\/doi.org\/10.1016\/j.ahj.2013.11.004.","journal-title":"Am. heart J."},{"key":"4028_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.12793\/tcp.2018.26.4.145","volume":"26","author":"DS Yim","year":"2018","unstructured":"Yim, D. S. Five years of the cipa project (2013\u20132018)-what did we learn? Transl. Clin. Pharmacol. 26:145\u2013149, 2018. https:\/\/doi.org\/10.12793\/tcp.2018.26.4.145.","journal-title":"Transl. Clin. Pharmacol."},{"key":"4028_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002061","author":"T O\u2019Hara","year":"2011","unstructured":"O\u2019Hara, T., L. Vir\u00e1g, A. Varr\u00f3, and Y. Rudy. Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation. PLoS Comput. Biol. 2011. https:\/\/doi.org\/10.1371\/journal.pcbi.1002061.","journal-title":"PLoS Comput. Biol"},{"key":"4028_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.116.004628","author":"Z Li","year":"2017","unstructured":"Li, Z., S. Dutta, J. Sheng, P. N. Tran, W. Wu, K. Chang, T. Mdluli, D. G. Strauss, and T. Colatsky. Improving the in silico assessment of proarrhythmia risk by combining hERG (Human Ether-\u00e0-go-go-Related Gene) channel-drug binding kinetics and multichannel pharmacology. Circ. Arrhythmia Electrophysiol. 2017. https:\/\/doi.org\/10.1161\/CIRCEP.116.004628.","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"4028_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2023.1266084","volume":"14","author":"YN Fuadah","year":"2023","unstructured":"Fuadah, Y. N., A. I. Qauli, A. Marcellinus, M. A. Pramudito, and K. M. Lim. Machine learning approach to evaluate TdP risk of drugs using cardiac electrophysiological model including inter-individual variability. Front. Physiol. 14:1\u201318, 2023. https:\/\/doi.org\/10.3389\/fphys.2023.1266084.","journal-title":"Front. Physiol."},{"key":"4028_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.367","author":"MC Lancaster","year":"2016","unstructured":"Lancaster, M. C., and E. A. Sobie. Improved prediction of drug-induced torsades de pointes through simulations of dynamics and machine learning algorithms. Clin. Pharmacol. Ther. 2016. https:\/\/doi.org\/10.1002\/cpt.367.","journal-title":"Clin. Pharmacol. Ther."},{"key":"4028_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.761691","author":"Y Yoo","year":"2021","unstructured":"Yoo, Y., A. Marcellinus, D. U. Jeong, K. S. Kim, and K. M. Lim. Assessment of drug proarrhythmicity using artificial neural networks with in silico deterministic model outputs. Front. Physiol. 2021. https:\/\/doi.org\/10.3389\/fphys.2021.761691.","journal-title":"Front. Physiol."},{"key":"4028_CR16","doi-asserted-by":"publisher","first-page":"5172","DOI":"10.1021\/acs.jcim.0c00201","volume":"60","author":"J Llopis-Lorente","year":"2020","unstructured":"Llopis-Lorente, J., J. Gomis-Tena, J. Cano, L. Romero, J. Saiz, and B. Trenor. In silico classifiers for the assessment of drug proarrhythmicity. J. Chem. Inf. Model. 60:5172\u20135187, 2020. https:\/\/doi.org\/10.1021\/acs.jcim.0c00201.","journal-title":"J. Chem. Inf. Model."},{"key":"4028_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71169-w","author":"MA Pramudito","year":"2024","unstructured":"Pramudito, M. A., Y. N. Fuadah, A. I. Qauli, A. Marcellinus, and K. M. Lim. Explainable artificial intelligence (XAI) to find optimal in-silico biomarkers for cardiac drug toxicity evaluation. Sci. Rep. 2024. https:\/\/doi.org\/10.1038\/s41598-024-71169-w.","journal-title":"Sci. Rep."},{"key":"4028_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2025.108609","author":"AI Qauli","year":"2025","unstructured":"Qauli, A. I., U. L. Hanum, F. J. Vanheusden, and K. M. Lim. Elevating performance and interpretability of in silico classifiers for drug proarrhythmia risk evaluations using multi-biomarker approach with ranking algorithm. Comput. Methods Programs Biomed. 2025. https:\/\/doi.org\/10.1016\/j.cmpb.2025.108609.","journal-title":"Comput. Methods Programs Biomed"},{"key":"4028_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01054","author":"J Parikh","year":"2019","unstructured":"Parikh, J., P. Di Achille, J. Kozloski, and V. Gurev. Global sensitivity analysis of ventricular myocyte model-derived metrics for proarrhythmic risk assessment. Front. Pharmacol. 2019. https:\/\/doi.org\/10.3389\/fphar.2019.01054.","journal-title":"Front. Pharmacol"},{"key":"4028_CR20","doi-asserted-by":"publisher","DOI":"10.12793\/tcp.2024.32.e7","author":"AI Qauli","year":"2024","unstructured":"Qauli, A. I., R. Z. Danadibrata, A. Marcellinus, and K. M. Lim. Development of in-silico drug cardiac toxicity evaluation system with consideration of inter-individual variability. Transl. Clin. Pharmacol. 2024. https:\/\/doi.org\/10.12793\/tcp.2024.32.e7.","journal-title":"Transl. Clin. Pharmacol."},{"key":"4028_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-29208-5","author":"AI Qauli","year":"2023","unstructured":"Qauli, A. I., A. Marcellinus, M. A. Setiawan, A. F. N. Zain, A. M. Pinandito, and K. M. Lim. In silico assessment on TdP risks of drug combinations under CiPA paradigm. Sci. Rep. 2023. https:\/\/doi.org\/10.1038\/s41598-023-29208-5.","journal-title":"Sci. Rep."},{"key":"4028_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/cpt.1184","volume":"105","author":"Z Li","year":"2019","unstructured":"Li, Z., B. J. Ridder, X. Han, W. W. Wu, J. Sheng, P. N. Tran, M. Wu, A. Randolph, R. H. Johnstone, G. R. Mirams, Y. Kuryshev, J. Kramer, C. Wu, W. J. Crumb, and D. G. Strauss. Assessment of an in silico mechanistic model for proarrhythmia risk prediction under the CiPA initiative. Clin. Pharmacol. Ther. 105:466\u2013475, 2019. https:\/\/doi.org\/10.1002\/cpt.1184.","journal-title":"Clin. Pharmacol. Ther."},{"key":"4028_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00668","author":"E Passini","year":"2017","unstructured":"Passini, E., O. J. Britton, H. R. Lu, J. Rohrbacher, A. N. Hermans, D. J. Gallacher, R. J. H. Greig, A. Bueno-Orovio, and B. Rodriguez. Human in silico drug trials demonstrate higher accuracy than animal models in predicting clinical pro-arrhythmic cardiotoxicity. Front. Physiol. 2017. https:\/\/doi.org\/10.3389\/fphys.2017.00668.","journal-title":"Front. Physiol."},{"key":"4028_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2022.992650","author":"C Trovato","year":"2022","unstructured":"Trovato, C., M. Mohr, F. Schmidt, E. Passini, and B. Rodriguez. Cross clinical-experimental-computational qualification of in silico drug trials on human cardiac purkinje cells for proarrhythmia risk prediction. Front. Toxicol. 2022. https:\/\/doi.org\/10.3389\/ftox.2022.992650.","journal-title":"Front. Toxicol."},{"key":"4028_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00616","author":"S Dutta","year":"2017","unstructured":"Dutta, S., K. C. Chang, K. A. Beattie, J. Sheng, P. N. Tran, W. W. Wu, M. Wu, D. G. Strauss, T. Colatsky, and Z. Li. Optimization of an in silico cardiac cell model for proarrhythmia risk assessment. Front. Physiol. 2017. https:\/\/doi.org\/10.3389\/fphys.2017.00616.","journal-title":"Front. Physiol."},{"key":"4028_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00917","author":"KC Chang","year":"2017","unstructured":"Chang, K. C., S. Dutta, G. R. Mirams, K. A. Beattie, J. Sheng, P. N. Tran, M. Wu, W. W. Wu, T. Colatsky, D. G. Strauss, and Z. Li. Uncertainty quantification reveals the importance of data variability and experimental design considerations for in silico proarrhythmia risk assessment. Front. Physiol. 2017. https:\/\/doi.org\/10.3389\/fphys.2017.00917.","journal-title":"Front. Physiol."},{"key":"4028_CR27","doi-asserted-by":"crossref","unstructured":"Antzelevitch, C., G.-X. Yan, and W. Shimizu. Transmural dispersion of repolarization and arrhythmogenicity the brugada syndrome versus the long QT syndrome. 1999.","DOI":"10.1016\/S0022-0736(99)90074-2"},{"key":"4028_CR28","doi-asserted-by":"crossref","unstructured":"Yan, G.-X., and C. Antzelevitch. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. 1998.at <http:\/\/ahajournals.org>","DOI":"10.1016\/S0022-0736(98)80063-0"},{"key":"4028_CR29","unstructured":"Liu, D.-W., G. A. Gintant, and C. Antzelevitch. Ionic Bases for Electrophysiological Distinctions Among Epicardial, Midmyocardial, and Endocardial Myocytes From the Free Wall of the Canine Left Ventricle WORDs * ventricular myocardium * epicardium * endocardium * midmyocardium M cells * electrophysiology * heterogeneity * ionic currents * transient outward currents * inward rectifier currentsat <http:\/\/ahajournals.org>"},{"key":"4028_CR30","unstructured":"Lukas, A., V. Wall Subepicardial, and S. Cells. Electrophysiology of myocardial cells in the epicardial, midmyocardial, and endocardial layers of the ventricle electrophysiology of the early electrophysiologic studies employed tissues ob-tained primarily from the epicardial and endocardial at Nanyang Tech Univ Library on. 2015."},{"key":"4028_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2004.09.011","author":"C Antzelevitch","year":"2005","unstructured":"Antzelevitch, C. Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes. Hear. Rhythm. 2005. https:\/\/doi.org\/10.1016\/j.hrthm.2004.09.011.","journal-title":"Hear. Rhythm"},{"key":"4028_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12938-019-0640-7","author":"N Dusturia","year":"2019","unstructured":"Dusturia, N., S. W. Choi, K. S. Song, and K. M. Lim. Effect of myocardial heterogeneity on ventricular electro-mechanical responses: a computational study. Biomed. Eng. Online. 2019. https:\/\/doi.org\/10.1186\/s12938-019-0640-7.","journal-title":"Biomed. Eng. Online"},{"key":"4028_CR33","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00024.2019","author":"V Andr\u00e1s","year":"2021","unstructured":"Andr\u00e1s, V., J. Tomek, N. Nagy, L. Vir\u00e1g, E. Passini, B. Rodriguez, and I. Baczk\u00f3. Cardiac transmembrane ion channels and action potentials: cellular physiology and arrhythmogenic behavior. Physiol. Rev. 2021. https:\/\/doi.org\/10.1152\/physrev.00024.2019.","journal-title":"Physiol. Rev."},{"key":"4028_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003607","author":"SB Prenner","year":"2016","unstructured":"Prenner, S. B., S. J. Shah, J. J. Goldberger, and A. J. Sauer. Repolarization heterogeneity: beyond the QT interval. J. Am. Heart Assoc. 2016. https:\/\/doi.org\/10.1161\/JAHA.116.003607.","journal-title":"J. Am. Heart Assoc."},{"key":"4028_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00816","author":"J Parikh","year":"2017","unstructured":"Parikh, J., V. Gurev, and J. J. Rice. Novel two-step classifier for Torsades de Pointes risk stratification from direct features. Front. Pharmacol. 2017. https:\/\/doi.org\/10.3389\/fphar.2017.00816.","journal-title":"Front. Pharmacol."},{"key":"4028_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/cpt.1647","volume":"107","author":"Z Li","year":"2020","unstructured":"Li, Z., et al. General principles for the validation of proarrhythmia risk prediction models: an extension of the cipa in silico strategy. Clin. Pharmacol. Ther. 107:102\u2013111, 2020. https:\/\/doi.org\/10.1002\/cpt.1647.","journal-title":"Clin. Pharmacol. Ther."},{"key":"4028_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cvr\/cvr044","volume":"91","author":"GR Mirams","year":"2011","unstructured":"Mirams, G. R., Y. Cui, A. Sher, M. Fink, J. Cooper, B. M. Heath, N. C. McMahon, D. J. Gavaghan, and D. Noble. Simulation of multiple ion channel block provides improved prediction of compounds\u2019 clinical torsadogenic risk. Cardiovasc. Res. 91:53\u201361, 2011. https:\/\/doi.org\/10.1093\/cvr\/cvr044.","journal-title":"Cardiovasc. Res."},{"key":"4028_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.1080190","author":"DU Jeong","year":"2022","unstructured":"Jeong, D. U., N. QashriMahardika T, A. Marcellinus, and K. M. Lim. qInward variability-based in-silico proarrhythmic risk assessment of drugs using deep learning model. Front. Physiol. 2022. https:\/\/doi.org\/10.3389\/fphys.2022.1080190.","journal-title":"Front. Physiol."},{"key":"4028_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1374355","author":"TNQ Mahardika","year":"2024","unstructured":"Mahardika, T. N. Q., A. I. Qauli, A. Marcellinus, and K. M. Lim. Evaluation of cardiac pro-arrhythmic risks using the artificial neural network with ToR\u2013ORd in silico model output. Front. Physiol. 2024. https:\/\/doi.org\/10.3389\/fphys.2024.1374355.","journal-title":"Front. Physiol."},{"key":"4028_CR40","doi-asserted-by":"publisher","first-page":"50796","DOI":"10.1021\/acsomega.4c09356","volume":"9","author":"YN Fuadah","year":"2024","unstructured":"Fuadah, Y. N., M. A. Pramudito, L. Firdaus, F. J. Vanheusden, and K. M. Lim. QSAR classification modeling using machine learning with a consensus-based approach for multivariate chemical hazard end points. ACS Omega. 9:50796\u201350808, 2024. https:\/\/doi.org\/10.1021\/acsomega.4c09356.","journal-title":"ACS Omega"},{"key":"4028_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-59821-7","volume":"10","author":"J Zheng","year":"2020","unstructured":"Zheng, J., H. Chu, D. Struppa, J. Zhang, S. M. Yacoub, H. El-Askary, A. Chang, L. Ehwerhemuepha, I. Abudayyeh, A. Barrett, G. Fu, H. Yao, D. Li, H. Guo, and C. Rakovski. Optimal multi-stage arrhythmia classification approach. Sci. Rep. 10:1\u201317, 2020. https:\/\/doi.org\/10.1038\/s41598-020-59821-7.","journal-title":"Sci. Rep."},{"key":"4028_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.1009647","author":"DU Jeong","year":"2022","unstructured":"Jeong, D. U., R. Z. Danadibrata, A. Marcellinus, and K. M. Lim. Validation of in silico biomarkers for drug screening through ordinal logistic regression. Front. Physiol. 2022. https:\/\/doi.org\/10.3389\/fphys.2022.1009647.","journal-title":"Front. Physiol."},{"key":"4028_CR43","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1002\/sim.1358","volume":"21","author":"K Van Steen","year":"2002","unstructured":"Van Steen, K., D. Curran, J. Kramer, G. Molenberghs, A. Van Vreckem, A. Bottomley, and R. Sylvester. Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: Identification and impact on model selection. Stat. Med. 21:3865\u20133884, 2002. https:\/\/doi.org\/10.1002\/sim.1358.","journal-title":"Stat. Med."},{"key":"4028_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-0587.2012.07348.x","volume":"36","author":"CF Dormann","year":"2013","unstructured":"Dormann, C. F., J. Elith, S. Bacher, C. Buchmann, G. Carl, G. Carr\u00e9, J. R. G. Marqu\u00e9z, B. Gruber, B. Lafourcade, P. J. Leit\u00e3o, T. M\u00fcnkem\u00fcller, C. Mcclean, P. E. Osborne, B. Reineking, B. Schr\u00f6der, A. K. Skidmore, D. Zurell, and S. Lautenbach. Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. Ecography (Cop.). 36:27\u201346, 2013. https:\/\/doi.org\/10.1111\/j.1600-0587.2012.07348.x.","journal-title":"Ecography (Cop.)"},{"key":"4028_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-025-94857-7","volume":"15","author":"N Akhtar","year":"2025","unstructured":"Akhtar, N., and M. F. Alharthi. Enhancing accuracy in modelling highly multicollinear data using alternative shrinkage parameters for ridge regression methods. Sci. Rep. 15:1\u201313, 2025. https:\/\/doi.org\/10.1038\/s41598-025-94857-7.","journal-title":"Sci. Rep."},{"key":"4028_CR46","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S0008-6363(99)00035-8","volume":"42","author":"PC Viswanathan","year":"1999","unstructured":"Viswanathan, P. C., and Y. Rudy. Pause induced early afterdepolarizations in the long QT syndrome: a simulation study. Cardiovasc. Res. 42:530\u2013542, 1999. https:\/\/doi.org\/10.1016\/S0008-6363(99)00035-8.","journal-title":"Cardiovasc. Res."},{"key":"4028_CR47","doi-asserted-by":"publisher","first-page":"108293","DOI":"10.1016\/j.cmpb.2024.108293","volume":"254","author":"F Escobar","year":"2024","unstructured":"Escobar, F., S. Friis, N. Adly, N. Brinkwirth, J. Gomis-Tena, J. Saiz, D. A. Klaerke, S. Stoelzle-Feix, and L. Romero. Experimentally validated modeling of dynamic drug-hERG channel interactions reproducing the binding mechanisms and its importance in action potential duration. Comput. Methods Programs Biomed. 254:108293, 2024. https:\/\/doi.org\/10.1016\/j.cmpb.2024.108293.","journal-title":"Comput. Methods Programs Biomed."},{"key":"4028_CR48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4330\/wjc.v5.i6.175","volume":"5","author":"A Konstantopoulou","year":"2013","unstructured":"Konstantopoulou, A. Mechanisms of drug-induced proarrhythmia in clinical practice. World J. Cardiol. 5:175, 2013. https:\/\/doi.org\/10.4330\/wjc.v5.i6.175.","journal-title":"World J. Cardiol."},{"key":"4028_CR49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/09720502.2010.10700699","volume":"13","author":"H Midi","year":"2010","unstructured":"Midi, H., S. K. Sarkar, and S. Rana. Collinearity diagnostics of binary logistic regression model. J. Interdiscip. Math. 13:253\u2013267, 2010. https:\/\/doi.org\/10.1080\/09720502.2010.10700699.","journal-title":"J. Interdiscip. Math."},{"key":"4028_CR50","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zou","year":"2005","unstructured":"Zou, H., and T. Hastie. Regularization and variable selection via the elastic net. J. R. Stat. Soc. Ser. B Stat. Methodol. 67:301\u2013320, 2005. https:\/\/doi.org\/10.1111\/j.1467-9868.2005.00503.x.","journal-title":"Stat. Soc. Ser. B Stat. Methodol."},{"key":"4028_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/widm.1249","author":"O Sagi","year":"2018","unstructured":"Sagi, O., and L. Rokach. Ensemble learning: a survey wiley interdiscip. Rev. Data Min. Knowl. Discov. 2018. https:\/\/doi.org\/10.1002\/widm.1249.","journal-title":"Rev. Data Min. Knowl. Discov."},{"key":"4028_CR52","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1007\/s40747-022-00809-3","volume":"9","author":"S Shafieian","year":"2023","unstructured":"Shafieian, S., and M. Zulkernine. Multi-layer stacking ensemble learners for low footprint network intrusion detection. Complex Intell. Syst. 9:3787\u20133799, 2023. https:\/\/doi.org\/10.1007\/s40747-022-00809-3.","journal-title":"Complex Intell. Syst."},{"key":"4028_CR53","doi-asserted-by":"publisher","first-page":"120462","DOI":"10.1016\/j.eswa.2023.120462","volume":"229","author":"J P\u00e9rez-Rodr\u00edguez","year":"2023","unstructured":"P\u00e9rez-Rodr\u00edguez, J., F. Fern\u00e1ndez-Navarro, and T. Ashley. Estimating ensemble weights for bagging regressors based on the mean\u2013variance portfolio framework. Expert Syst. Appl. 229:120462, 2023. https:\/\/doi.org\/10.1016\/j.eswa.2023.120462.","journal-title":"Expert Syst. Appl."},{"key":"4028_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2023.1110555","volume":"14","author":"HJ Farm","year":"2023","unstructured":"Farm, H. J., M. Clerx, F. Cooper, L. Polonchuk, K. Wang, D. J. Gavaghan, and C. L. Lei. Importance of modelling hERG binding in predicting drug-induced action potential prolongations for drug safety assessment. Front. Pharmacol. 14:1\u201312, 2023. https:\/\/doi.org\/10.3389\/fphar.2023.1110555.","journal-title":"Front. Pharmacol."},{"key":"4028_CR55","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/jce.12289","volume":"25","author":"GY Di Veroli","year":"2014","unstructured":"Di Veroli, G. Y., M. R. Davies, H. Zhang, N. Abi-Gerges, and M. R. Boyett. HERG inhibitors with similar potency but different binding kinetics do not pose the same proarrhythmic risk: Implications for drug safety assessment. J. Cardiovasc. Electrophysiol. 25:197\u2013207, 2014. https:\/\/doi.org\/10.1111\/jce.12289.","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"4028_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2020.106890","author":"X Han","year":"2020","unstructured":"Han, X., M. Samieegohar, B. J. Ridder, W. W. Wu, A. Randolph, P. Tran, J. Sheng, S. Stoelzle-Feix, N. Brinkwirth, M. G. Rotordam, N. Becker, S. Friis, M. Rapedius, T. A. Goetze, T. Strassmaier, G. Okeyo, J. Kramer, Y. Kuryshev, C. Wu, D. G. Strauss, and Z. Li. A general procedure to select calibration drugs for lab-specific validation and calibration of proarrhythmia risk prediction models: An illustrative example using the CiPA model. J. Pharmacol. Toxicol. Methods. 2020. https:\/\/doi.org\/10.1016\/j.vascn.2020.106890.","journal-title":"J. Pharmacol. Toxicol. Methods"}],"container-title":["Annals of Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10439-026-04028-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10439-026-04028-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10439-026-04028-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:42:43Z","timestamp":1787838163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10439-026-04028-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4028"],"URL":"https:\/\/doi.org\/10.1007\/s10439-026-04028-6","relation":{},"ISSN":["0090-6964","1573-9686"],"issn-type":[{"value":"0090-6964","type":"print"},{"value":"1573-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KML is employed by Meta Heart Inc. The other authors declare that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Competing Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}